W 725 (Divalproex sodium extended-release 500 mg)

Pill imprint W 725 has been identified as Divalproex sodium extended-release 500 mg.

Divalproex sodium is used in the treatment of bipolar disorder; migraine prevention; mania; epilepsy; hyperekplexia (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for W 725 (Divalproex sodium extended-release 500 mg)

Divalproex sodium extended-release 500 mg W 725
Divalproex sodium extended-release
Imprint:
W 725
Strength:
500 mg
Color:
Gray
Size:
19.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Wockhardt USA
National Drug Code (NDC):
64679-0725
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0317 Amerisource Health Services
00904-6073 Major Pharmaceuticals

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web5)